ENO1 and B-cell chronic lymphocytic leukemia: Circulating anti-ENO1 antibodies have also been detected in blood from chronic lymphocytic leukaemia patients with progressive disease [18], suggesting a possible predictive role for this biomarker in haematological malignancies.